Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for BGLAF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 23.40%
March 31, 2026 21.32%
December 31, 2025 22.42%
September 30, 2025 20.17%
June 30, 2025 21.72%
March 31, 2025 21.90%
December 31, 2024 22.46%
September 30, 2024 12.04%
June 30, 2024 28.90%
March 31, 2024 32.95%
December 31, 2023 22.62%
September 30, 2023 31.95%
June 30, 2023 25.55%
March 31, 2023 31.69%
December 31, 2022 50.76%
September 30, 2022 30.85%
June 30, 2022 27.26%
March 31, 2022 26.88%
December 31, 2021 18.57%
September 30, 2021 30.40%
June 30, 2021 26.93%
March 31, 2021 24.97%
December 31, 2020 20.50%
September 30, 2020 15.52%
June 30, 2020 32.30%
Date Value
March 31, 2020 22.84%
December 31, 2019 24.53%
September 30, 2019 22.76%
June 30, 2019 27.46%
March 31, 2019 20.78%
December 31, 2018 27.16%
September 30, 2018 29.41%
June 30, 2018 31.24%
March 31, 2018 27.55%
December 31, 2017 28.42%
September 30, 2017 28.54%
June 30, 2017 30.23%
March 31, 2017 30.39%
December 31, 2016 33.86%
September 30, 2016 27.82%
June 30, 2016 28.35%
March 31, 2016 28.95%
December 31, 2015 25.06%
September 30, 2015 19.50%
June 30, 2015 26.63%
March 31, 2015 31.14%
December 31, 2014 15.71%
September 30, 2014 18.14%
June 30, 2014 18.99%
March 31, 2014 51.41%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Hansa Biopharma AB -541.7%
BioArctic AB -4.51%
Swedish Orphan Biovitrum AB 14.00%
Diamyd Medical AB -184.8K%
BONESUPPORT HOLDING AB 23.02%